| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |